Surrozen, Inc. Schedules Third Quarter 2026 Earnings Announcement
Surrozen, Inc. has scheduled the release of its financial results for the third quarter of 2026 for November 11, 2026.
Stocks · News reference
U.S. stocks fell Thursday as tech slid; jobless claims beat estimates. Oil rose, while APUS surged 245% and BENF plunged 33%.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Surrozen, Inc. has scheduled the release of its financial results for the third quarter of 2026 for November 11, 2026.
Quadrise PLC provided an update on its project with Valkor Technologies, noting VSA Capital Limited's role as a joint broker.
Emmerson PLC has scheduled its Annual General Meeting for November 26, 2026, with VSA Capital Limited serving as a joint broker.
Artelo Biosciences announced it will present nonclinical data for ART27.13, a candidate for chemotherapy-induced neuropathic pain, at the IASP 2026 World Congress on Pain.
Beneficient has initiated legal proceedings to invalidate purported debt obligations linked to its former CEO, Brad Heppner, as part of a strategy to achieve a complete separation from him and his affiliated entities.